ADHD Medication + Parent Training for ADHD Families
(TPAC Trial)
Trial Summary
What is the purpose of this trial?
This study will compare the effectiveness of combined parental stimulant medication and behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and parental ADHD impairment, parental ADHD symptoms, parenting, and BPT engagement (parental outcomes/target mechanisms). This study will also assess the care delivery context and develop an implementation approach for treatment of families with a parent with ADHD and a child with elevated ADHD symptoms via telehealth in primary care sites providing pediatric care.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on an antidepressant, it must be well-tolerated, unchanged for 30 days, and approved by your doctor for participation. If you have taken stimulant medication for ADHD in the past 30 days, you may not be eligible.
What data supports the effectiveness of the treatment Behavioral Parent Training (BPT) for ADHD families?
Is Behavioral Parent Training (BPT) safe for families with children who have ADHD?
How is the ADHD Medication + Parent Training treatment different from other ADHD treatments?
This treatment is unique because it combines behavioral parent training (BPT) with extended-release mixed amphetamine salts (MAS), addressing both the child's and the parent's ADHD symptoms. This dual approach is particularly beneficial for families where both the parent and child have ADHD, as it improves parenting practices and child outcomes more effectively than medication or behavioral training alone.13478
Research Team
Andrea Chronis-Tuscano, Ph.D.
Principal Investigator
University of Maryland, College Park
Eligibility Criteria
This trial is for parents over 21 with ADHD and their children aged 3-8 who may also have ADHD symptoms. Parents must meet full criteria for ADHD, be in good physical health, not pregnant, and agree to use contraception if applicable. Children should not have been on stimulant medications before or only tried them without success.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Parents receive stimulant medication and behavioral parent training, while children receive behavioral parent training with potential recommendation for stimulant medication
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Behavioral Parent Training
- Extended release mixed amphetamine salts (MAS)
Behavioral Parent Training is already approved in United States, European Union, Canada for the following indications:
- Disruptive Behavior Disorder
- Oppositional Defiant Disorder
- Conduct Disorder
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Anxiety with behavioral difficulties
- Disruptive Mood Dysregulation Disorder (DMDD)
- Intermittent Explosive Disorder (IED)
- Disruptive Behavior Disorder
- Oppositional Defiant Disorder
- Conduct Disorder
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Anxiety with behavioral difficulties
- Disruptive Behavior Disorder
- Oppositional Defiant Disorder
- Conduct Disorder
- Attention-Deficit/Hyperactivity Disorder (ADHD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, College Park
Lead Sponsor
Children's National Research Institute
Collaborator
University of Michigan
Collaborator
Seattle Children's Hospital
Collaborator
National Institute of Mental Health (NIMH)
Collaborator